GLP-1 Safety Center
Your independent safety resource for Ozempic, Wegovy, Mounjaro, and Zepbound. We track FDA enforcement actions, document side effects, verify providers, and follow active litigation so you can make informed decisions about GLP-1 medications.
Side Effects Guide
Comprehensive breakdown of GLP-1 side effects from common GI issues to rare but serious complications. Know what to expect and when to seek help.
Managing Side Effects
Practical, evidence-based strategies for managing common GLP-1 side effects like nausea, constipation, and fatigue. Tips from gastroenterologists and patients.
FDA Safety Alerts
Real-time tracking of FDA warning letters, recalls, and enforcement actions against GLP-1 compounders and distributors.
Lawsuit Tracker
Follow active GLP-1 litigation including class actions against Novo Nordisk and Eli Lilly. Understand the legal landscape.
Scam Checker
Verify if your GLP-1 provider is legitimate. Red flags, green flags, and a step-by-step checklist to protect yourself from fraud.
Ozempic & Pregnancy
Critical safety information about GLP-1 medications and pregnancy. When to stop, waiting periods, fertility effects, and what the FDA recommends.
Warning: Compounded GLP-1 Medications
The FDA declared the semaglutide shortage officially over in February 2025, removing the legal basis for most compounding pharmacies to produce semaglutide copies. Despite this, many compounders continue to sell compounded semaglutide illegally. In March 2026, the FDA escalated enforcement by issuing warning letters to 12 additional compounders.
- FDA has warned companies over GLP-1 compounding and marketing, and lists dosing errors and salt forms among its concerns
- Some compounded products have been found to contain dangerously incorrect concentrations of semaglutide
- Compounded medications do not undergo the same quality testing as FDA-approved drugs
- Several patients have reported serious adverse events linked to compounded GLP-1 products
Worried about compounders? See listed providers.
All 6 programs on our shortlist use LegitScript-certified pharmacies and named US-licensed prescribers. No anonymous compounders.
Essential Safety Tips
Verify Your Provider
Always confirm your provider uses state-licensed pharmacies and has verifiable, named physicians on staff.
Start Low, Go Slow
GLP-1 medications should be titrated gradually. Any provider shipping you a high dose immediately is a red flag.
Report Problems
Report adverse events to the FDA MedWatch program and your state pharmacy board. Your report could protect others.
Medicare GLP-1 Coverage Since July 2026
Since July 1, 2026, the Medicare GLP-1 Bridge has covered Foundayo, Wegovy and the Zepbound KwikPen at $50/month for eligible enrollees. All three are FDA-approved medicines; compounded drugs are not covered. Read our full Medicare GLP-1 Bridge Program guide to understand eligibility and enrollment.
Not Sure About Your Provider?
Use our scam checker to verify legitimacy, or see our ranked providers.
What's next?
Now that you know the safety picture, start with a listed program. Embody is our listed pick: US-licensed prescribers, GLP-1 from $79/mo.
See Embody, from $79/mo →